In the current study, 78.6% of patients with elevated ALT/AST levels, 81.5% of patients with leukopenia, 76.8% of patients with elevated CK levels, 77.7% of patients with thrombocytopenia, 77.7% of patients with thrombocytopenia, and 77% of patients with elevated LDH levels were diagnosed as CCHF-positive. The gene discussed is GPT; the disease is Thrombocytopenia.